Article

A study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/C-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1

2023-06-29

Abstract excerpt

<title>Abstract</title> Background Resistant cells are a critical problem that reduce treatment efficacy of breast cancer. Nowadays, CIP2A and PD-L1 are considered as theraputical challenges in breast cancer, because of responsible for drug resistance and immune evasion respectively. Hence, identifying agents to suppress these factors is great of interest. Specifically, epigenetic drugs can be an effective ap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 93903a87-891c-5b3e-a69e-3b0b61877520
DOI: 10.21203/rs.3.rs-3097920/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/C-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1DOI 10.21203/rs.3.rs-3097920/v1Read

The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cellsSemantic proximity Read

Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer TreatmentSemantic proximity Read

Could valproic acid be an effective anticancer agent? The evidence so farSemantic proximity Read

The Effects of Chemotherapeutic Drugs on PD-L1 Gene Expression in Breast Cancer Cell LinesSemantic proximity Read

Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.Semantic proximity Read

CIP2A Inhibits PP2A in Human MalignanciesSemantic proximity Read

CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?Semantic proximity Read

Role of Differentially Expressed Proteins in Acquired Resistance to Cdk4/6 Inhibitor in Breast CancerSemantic proximity Read

TH301 Emerges as a Novel Anti-Oncogenic Agent for Human Pancreatic Cancer Cells: The Dispensable Roles of p53, CRY2 and BMAL1 in TH301-Induced CDKN1A/p21CIP1/WAF1 UpregulationSemantic proximity Read

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological ConditionsSemantic proximity Read

Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular TargetsSemantic proximity Read

Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer CellsSemantic proximity Read